News Conference News TCT 2020 Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results Michael O'Riordan October 16, 2020
News Daily News Which TAVR Device Is Best? Review Tackles Optimal Selection Michael O'Riordan September 09, 2020
News Conference News ESC 2020 Go With Aspirin Alone After TAVR When Anticoagulation Isn’t Needed: POPular TAVI Todd Neale August 30, 2020
News Daily News Should Guidelines Support TAVR for Low-Risk Patients? Two Views L.A. McKeown August 17, 2020
News Conference News TVT 2020 Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years Michael O'Riordan June 22, 2020
News Conference News TVT 2020 Newer TAVR Devices Reassure in Failed Surgical Valves Shelley Wood June 20, 2020
News Conference News TVT 2020 Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes L.A. McKeown June 19, 2020
News Daily News Cardiogenic Shock Spells Poor Outcomes Despite Successful TAVR Todd Neale June 02, 2020
News Conference News ACC 2020 Early Data Support TAVR in Bicuspid Valves, but Questions Remain Michael O'Riordan March 29, 2020
News Conference News ACC 2020 PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients Yael L. Maxwell March 29, 2020
News Conference News ACC 2020 UK TAVI: Real-world TAVR and SAVR Have Similar 1-Year Mortality L.A. McKeown March 29, 2020
News Conference News ACC 2020 A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI Todd Neale March 29, 2020
News Conference News CRT 2020 Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation Michael O'Riordan February 26, 2020
News Conference News STS 2020 For Congenital Heart Disease, SAVR With Bioprosthetic Valve Still Reigns Yael L. Maxwell January 30, 2020